Thailand’s experiment with cannabis liberalisation is undergoing a profound and contentious recalibration. The Ministry of Public Health (MOPH) is advancing a new draft ministerial regulation designed to impose stringent oversight on the sector, a decisive pivot away from the largely unregulated commercial free-for-all that emerged post-2022 and back towards a strictly medical framework. This shift, while framed as a necessary correction to safeguard public health, is causing significant industry consolidation, widespread business closures, and heated public debate.
The Regulatory Reversal: From Open Market to Medical Gatekeeping
The draft “Ministerial Regulation on Permits for Research, Export, Sale, or Processing of Controlled Herbs for Commercial Purposes” has received Cabinet approval and is under final review by the Office of the Council of State. It explicitly replaces the 2016 regulation, deemed wholly inadequate for the landscape that followed cannabis’s delisting as a narcotic in 2022. That delisting, while initially celebrated by entrepreneurs, created a regulatory vacuum, leading to the proliferation of over 20,000 dispensaries and hemp shops nationwide, many operating in a grey area with minimal controls.
The new regulation aims to dismantle this grey market. Its core principle is the restriction of commercial distribution to explicitly health-oriented venues: medical facilities where physicians prescribe and supervise dispensing, licensed pharmacies, authorised herbal product shops, and traditional Thai medicine clinics. This fundamentally excludes the general retail “cannabis cafe” or recreational dispensary model that flourished in tourist areas. As Public Health Minister Somsak Thepsutin stated to Bangkok Post, “The new law will clearly define that cannabis is for medical use only… The free use of cannabis will be over.”
Operational Earthquake: Compliance Costs and Mandatory Upgrades
For existing dispensaries and cultivators, the draft stipulates operational mandates that pose significant financial and logistical hurdles. Premises must have legally verified ownership or possession. They must install efficient systems to eliminate odour and smoke, a direct response to community complaints about public nuisance. Dedicated storage with controlled temperature and humidity, with products elevated from direct floor contact, is compulsory. Perhaps most critically, at least one employee certified by the Department of Thai Traditional and Alternative Medicine must be on duty at all times.
These requirements, particularly the need for a certified professional, redefine the business from a retail operation to a quasi-healthcare outlet. An anonymous owner of three dispensaries in Bangkok explained to Thai PBS World, “The cost of compliance is not just about renovations. Hiring a qualified traditional medicine practitioner full-time doubles my payroll for each shop. For small businesses, this is not a regulation, it’s an eviction notice.”
This sentiment is reflected in recent licensing data: of the 8,636 licenses expiring in 2025, only 1,339, a mere 15.5%, were renewed, leading to over 7,297 closures. With thousands more licenses expiring in 2026 and 2027, a drastic industry downsizing is already underway.
Industry Contraction and Social Media Backlash
Many operators are choosing closure over change, anticipating that the compliance costs and narrowed customer base—limited to those with prescriptions or seeking traditional medicine—will render their businesses unviable. The estimated number of remaining outlets has plummeted from a peak of nearly 20,000 to approximately 11,136.
This rapid contraction has ignited fierce discourse on social media, where the hashtag #SaveThaiCannabis has trended periodically. Entrepreneurs and consumers share stories of lost investments and anxiety over the return of a black market.
“They invited us to plant the seeds, we invested our lives, and now they are burning the field,” posted one popular cannabis influencer on X (formerly Twitter), capturing the sense of betrayal felt by many early adopters.
Conversely, supportive voices online and in editorials, like one in The Nation, argue that the correction was inevitable, stating, “The unchecked commercialisation threatened to create a public health crisis, particularly among youth. The state’s primary duty is to protect its citizens, not commercial interests.”
Patient Protections and the Medical Pathway Forward
Amid the commercial turmoil, the MOPH has consistently emphasised protections for legitimate therapeutic users. The ministry guarantees “uninterrupted access for patients requiring cannabis therapeutically through hospital-based prescriptions,” asserting that there are sufficient qualified medical professionals nationwide to support the framework.
This ensures that patients relying on cannabis for conditions like chronic pain or chemotherapy-induced nausea will continue to have a regulated, quality-controlled supply, a system arguably more robust than the previous patchwork of dispensary recommendations.
Conclusion: A Defined, Yet Diminished, Future
Thailand’s cannabis journey is entering a much more restrictive chapter. The impending regulation clearly prioritises medical and traditional applications within a tightly controlled supply chain. While this promises greater consumer safety and aligns with international drug control treaties, a factor often cited by government officials, it comes at the cost of a decimated commercial sector and significant financial losses for thousands of entrepreneurs.
The final implementation timeline hinges on the completion of the legislative review, but the policy direction is set. However, as with all Thai policy, a note of political uncertainty remains. As noted by health policy analyst Dr. Poonpat Leesakul in a Khaosod English interview, “This draft is a product of the current administration and its public health priorities. The broader legal framework, the much-debated Cannabis Act, remains stalled in parliament. The ultimate shape of Thailand’s cannabis industry may yet be influenced by future political shifts.”
For now, the era of the wide-open cannabis shop is closing, making way for a system where the plant is treated not as a commodity, but as a controlled herb.
Contact us to assist your business through these changes.
As a well-respected, established cannabis law firm staffed by legal professionals with deep industry knowledge, Formichella & Sritawat is a good choice to assist you in navigating these regulatory changes and continuing as a viable, legal business.
